Podovirus

Discussion of Phage Therapy for CF Patients - Rebekah Dedrick

Rebekah Dedrick shares her background in phage research and her transition to the Cystic Fibrosis (CF) Foundation. She explains how her work with mycobacteriophages inter

Cell-free synthesis for the clinic: How Invitris is building a phage printer

What if you could build biology in a tube, no cells required? Invitris is a Munich-based cell-free synthesis company starting with bacteriophages. Kilian Vogele, co-found

Why phage companies aren’t raising $400M rounds… yet | Paul Garofolo

“The thing everybody thinks is a tailwind for our space — the low financial barrier to get into a clinical trial — is actually one of the largest headwinds.” Paul has sp

Chip Schooley & Graham Hatfull: the state of phage therapy (& what HIV can teach us)

Chip Schooley (UC San Diego, IPATH) and Graham Hatfull (University of Pittsburgh) join us to discuss why phage therapy needs biologists and clinicians collaborating — and

How to run a phage therapy center from your academic lab

What does it take to build a phage therapy program from nothing — and keep your research lab running at the same time? In this episode, Joe and I sat down with Dr. Daria

AI-generated phages that work: ChatGPT for phage biologists?

Can AI design living organisms from scratch? Samuel King and Claudia Driscoll from the Arc Institute used genome language models to generate functional phages—and 16 of t

How to get successful outcomes with phage therapy: Saima Aslam, MD, MS

"When I first started, I was treating anything and everything in terms of ‘this is highly drug resistant and it's failed’. But I think I have a clearer idea now, at least

Dr. Marisa Azad, MD, PhD: Behind Canada's first prosthetic joint treatment with phage therapy

"It's unacceptable to just tell this poor patient, there's nothing I can do to help you... That's when I thought, okay, well, what about kind of pushing the boundaries a

How to navigate regulatory limbo: a Canadian phage therapy CEO's playbook

"Phages are not drugs. Every time they say, 'Did you go through regulatory?' I say, 'I can do regulatory, but I'm not a drug.' There's 145 components of the regulatory re

Why can't patients access phage therapy? Does FDA need to change, or do patients just need a voice?

"This feels just like the early days of the HIV crisis. People are dying, you're not hearing about it. We need a group like ACT UP to bring this to the public. We're not

Finally, phase 2 data! Inside BiomX's successful phage therapy trial with CEO Jonathan Solomon

"Finally, finally we have Phase 2 data. We put a dent in the theory that phage therapy doesn't work. Maybe it does work. Maybe it's worth taking a risk." Jonathan Solomo

Does every scientist need an AI co-scientist? How two professors solved a years-long viral mystery

"I was so biased. I knew too much and that's why we couldn't see the obvious answer that was right in front of us for years." In this episode of the Podovirus Podcast, w

What's the business case for phage therapy?

“Getting our foot through the door to any VC... As soon as they hear we're infectious disease, their eyes kind of get big. And then they hear we're antibacterial, their e

How to bring phages to market: Intralytix's food-to-pharma strategy

"Somebody's father, friend, husband just passed away in the most developed country in the world... from a simple infection that probably could have been treated in Georgi

Gina Suh, MD: What it's really like to treat patients with phage therapy

What's it like to be a doctor treating patients with phage therapy in the US today? Dr. Gina Suh, Mayo Clinic infectious disease physician, tells us: - How she establis

Jesus Fernandez-Rodriguez: How Eligo Bioscience edits gut bacteria with phages

Welcome to the Podovirus podcast, episode 3! In this episode, I talk with Jesus Fernandez-Rodriguez from Eligo Bioscience, a Paris-based biotech company pioneering microb

Getting phage research funded — Joe Campbell reflects on a career at NIAID

Welcome to the Podovirus podcast, episode 2! In this episode, Jessica talks with Dr. Joe Campbell, who recently retired as a program officer at the National Institute o

Why all phage researchers need to be in Australia this July

This is a very special week. We’re launching the first episode of our Podovirus podcast! We started this on a whim (I wanted to explore this format, since I love talking